Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 12;11(6):e0271623.
doi: 10.1128/spectrum.02716-23. Epub 2023 Nov 9.

Development and evaluation of the automated multipurpose molecular testing system PCRpack for high-throughput SARS-CoV-2 testing

Affiliations

Development and evaluation of the automated multipurpose molecular testing system PCRpack for high-throughput SARS-CoV-2 testing

Yasufumi Matsumura et al. Microbiol Spectr. .

Abstract

Accurate and fast molecular testing is important for the diagnosis and control of COVID-19. During patient surges in the COVID-19 pandemic, laboratories were challenged by a higher demand for molecular testing under skilled staff shortages. We developed an automated multipurpose molecular testing system, named PCRpack, for the rapid, high-throughput testing of infectious pathogens, including SARS-CoV-2. The system is provided in an all-in-one package, including a liquid handling instrument, a laboratory information management system, and other materials needed for testing operation; is highly customizable; and is easily implemented. PCRpack showed robust liquid handling performance, high clinical diagnostic performance, a shorter turn-around time with minimal hands-on time, and a high testing capacity. These features contribute to the rapid implementation of the high-performance and high-throughput molecular testing environment at any phase of the pandemic caused by SARS-CoV-2 or future emerging pathogens.

Keywords: COVID-19; RT-PCR; SARS-CoV-2; automation; liquid handling instrument.

PubMed Disclaimer

Conflict of interest statement

Y.M. received research funds from Beckman Coulter, Nippon Control System, Toyobo, and Precision System Science. M.N. received research funds from Beckman Coulter and Precision System Science. T.N. is an employee of Beckman Coulter, and K.K. is an employee of Nippon Control System. The funding organizations had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.

Figures

Fig 1
Fig 1
Components of the PCRpack system. The negative pressure clean booth has casters and is movable. The dimensions of the system are a height of 2,063 mm, width of 1,256 mm, and depth of 990 mm. The system requires two independent power supplies of 100 V and 15 A: one for the clean booth, including the liquid handler and laboratory information management system, and the other for the PCR instrument.
Fig 2
Fig 2
The workflow of the PCRpack system. The workflow was divided into six procedures, and each procedure included several test steps. A broken line between steps indicates that the below and above steps were performed simultaneously. Panels A to D are provided to explain the steps indicated by the characters within parentheses. In the “transfer samples to PCR plate” step (panel C), a maximum of 94 samples were transferred from specimen tubes to a temporary deep-well plate and then transferred from the deep-well plate to a 96-well PCR plate. After dispensing controls into the 96-well PCR plate, the system can be paused to perform a visual inspection of the 96-well PCR plate to verify the dispensing of reagents and samples.
Fig 3
Fig 3
Comparison of test times for each test step between the PCRpack and manual testing methods. Panel A shows the total elapsed time, and panel B shows the hands-on time. The raw data are available in Dataset S2.

References

    1. Mardian Y, Kosasih H, Karyana M, Neal A, Lau CY. 2021. Review of current COVID-19 diagnostics and opportunities for further development. Front Med (Lausanne) 8:615099. doi: 10.3389/fmed.2021.615099 - DOI - PMC - PubMed
    1. Sethuraman N, Jeremiah SS, Ryo A. 2020. Interpreting diagnostic tests for SARS-CoV-2. JAMA 323:2249–2251. doi: 10.1001/jama.2020.8259 - DOI - PubMed
    1. Matsumura Y, Nagao M, Yamamoto M, Tsuchido Y, Noguchi T, Shinohara K, Yukawa S, Inoue H, Ikeda T. 2022. Transmissibility of SARS-CoV-2 B.1.1.214 and alpha variants during 4 COVID-19 waves. Emerg Infect Dis 28:1569–1577. doi: 10.3201/eid2808.220420 - DOI - PMC - PubMed
    1. Nolte FS, Babady NE, Buchan BW, Capraro GA, Graf EH, Leber AL, McElvania E, Yao JDC. 2020. Responding to the challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): perspectives from the association for molecular pathology infectious disease subdivision leadership. J Mol Diagn 22:968–974. doi: 10.1016/j.jmoldx.2020.06.003 - DOI - PMC - PubMed
    1. Potter C, Kaushal N, Wroblewski K, Becker S, Nuzzo JB. 2022. Identifying operational challenges and solutions during the COVID-19 response among US public health laboratories. J Public Health Manag Pract 28:607–614. doi: 10.1097/PHH.0000000000001585 - DOI - PMC - PubMed